1	Joven	joven	NCCS000	C0332239	calificador	0-5	310_QUEST_clinical_caseMIR	SENT1	-	-
2	de	de	SPS00	C0332285	atributo	6-8	310_QUEST_clinical_caseMIR	SENT1	-	-
3	24	24		-	-	9-11	310_QUEST_clinical_caseMIR	SENT1	-	-
4	años	año	NCMP000	C0439234	calificador	12-16	310_QUEST_clinical_caseMIR	SENT1	-	-
5	con	con	SPS00	C0332287	atributo	17-20	310_QUEST_clinical_caseMIR	SENT1	-	-
6	hipogonadismo	hipogonadismo	NC00SC0	C0020619	trastorno	21-34	310_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
7	de	de	SPS00	C0332285	atributo	35-37	310_QUEST_clinical_caseMIR	SENT1	-	-
8	origen	origen	NCMS000	C0439659	atributo	38-44	310_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
9	hipotalámico	hipotalámico	AQ0MS0	-	-	45-57	310_QUEST_clinical_caseMIR	SENT1	I-Grp_Enfermedad	-
10	secundario	secundario	NCMS000	C0175668_1	calificador_1	58-68	310_QUEST_clinical_caseMIR	SENT1	-	-
11	a	a	SPS00	C0175668_2	calificador_2	69-70	310_QUEST_clinical_caseMIR	SENT1	-	-
12	craneofaringioma	craneofaringioma	NC00SC0	C0010276	trastorno#anomalía_morfológica	71-87	310_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
13	intervenido	intervenir	VMP00SM	-	-	88-99	310_QUEST_clinical_caseMIR	SENT1	-	-
14	,	,	Fc	-	-	99-100	310_QUEST_clinical_caseMIR	SENT1	-	-
15	en	en	SPS00	C1720294#C0332285	calificador#atributo	101-103	310_QUEST_clinical_caseMIR	SENT1	-	-
16	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	104-115	310_QUEST_clinical_caseMIR	SENT1	-	-
17	sustitutivo	sustitutivo	AQ0MS0	-	-	116-127	310_QUEST_clinical_caseMIR	SENT1	-	-
18	con	con	SPS00	C0332287	atributo	128-131	310_QUEST_clinical_caseMIR	SENT1	-	-
19	undecanoato	undecanoato	NCMS000	C0076195_1	sustancia_1	132-143	310_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
20	de	de	SPS00	C0076195_2	sustancia_2	144-146	310_QUEST_clinical_caseMIR	SENT1	-	-
21	testosterona	testosterona	NCFS000	C0076195_3	sustancia_3	147-159	310_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
22	cada	cada	DI0CS0	C1457900	calificador	160-164	310_QUEST_clinical_caseMIR	SENT1	-	-
23	12	12		-	-	165-167	310_QUEST_clinical_caseMIR	SENT1	-	-
24	semanas	semana	NCFP000	C0439230	calificador	168-175	310_QUEST_clinical_caseMIR	SENT1	-	-
25	de	de	SPS00	C0332285	atributo	176-178	310_QUEST_clinical_caseMIR	SENT1	-	-
26	forma	forma	NCFS000	C0348078	atributo	179-184	310_QUEST_clinical_caseMIR	SENT1	-	-
27	intramuscular	intramuscular	AQ0CS0	C0442117	calificador	185-198	310_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
28	,	,	Fc	-	-	198-199	310_QUEST_clinical_caseMIR	SENT1	-	-
29	que	que	CS	-	-	200-203	310_QUEST_clinical_caseMIR	SENT1	-	-
30	nos	nos	PP1CP000	-	-	204-207	310_QUEST_clinical_caseMIR	SENT1	-	-
31	es	ser	VSIP3S0	-	-	208-210	310_QUEST_clinical_caseMIR	SENT1	-	-
32	remitido	remitir	VMP00SM	C0439600	calificador	211-219	310_QUEST_clinical_caseMIR	SENT1	-	-
33	desde	desde	SPS00	-	-	220-225	310_QUEST_clinical_caseMIR	SENT1	-	-
34	otro	otro	DI0MS0	C0205394#C0449210	calificador#estructura_corporal	226-230	310_QUEST_clinical_caseMIR	SENT1	-	-
35	centro	centro	NCMS000	C0205099	calificador	231-237	310_QUEST_clinical_caseMIR	SENT1	-	-
36	para	para	SPS00	C0521125	calificador	238-242	310_QUEST_clinical_caseMIR	SENT1	-	-
37	seguimiento	seguimiento	NCMS000	-	-	243-254	310_QUEST_clinical_caseMIR	SENT1	-	-
38	.	.	Fp	-	-	254-255	310_QUEST_clinical_caseMIR	SENT1	-	-

1	El	el	DA0MS0	-	-	256-258	310_QUEST_clinical_caseMIR	SENT2	-	-
2	paciente	paciente	NCCS000	C0030705	persona	259-267	310_QUEST_clinical_caseMIR	SENT2	-	-
3	nos	nos	PP1CP000	-	-	268-271	310_QUEST_clinical_caseMIR	SENT2	-	-
4	interroga	interrogar	VMIP3S0	-	-	272-281	310_QUEST_clinical_caseMIR	SENT2	-	-
5	en	en	SPS00	C1720294#C0332285	calificador#atributo	282-284	310_QUEST_clinical_caseMIR	SENT2	-	-
6	la	el	DA0FS0	-	-	285-287	310_QUEST_clinical_caseMIR	SENT2	-	-
7	visita	visita	NCFS000	-	-	288-294	310_QUEST_clinical_caseMIR	SENT2	-	-
8	inicial	inicial	AQ0CS0	C0205265	calificador	295-302	310_QUEST_clinical_caseMIR	SENT2	-	-
9	acerca	acercar	VMIP3S0	-	-	303-309	310_QUEST_clinical_caseMIR	SENT2	-	-
10	del	del	SP+DA	-	-	310-313	310_QUEST_clinical_caseMIR	SENT2	-	-
11	seguimiento	seguimiento	NCMS000	-	-	314-325	310_QUEST_clinical_caseMIR	SENT2	-	-
12	de	de	SPS00	C0332285	atributo	326-328	310_QUEST_clinical_caseMIR	SENT2	-	-
13	su	su	DP3CS0	-	-	329-331	310_QUEST_clinical_caseMIR	SENT2	-	-
14	patología	patología	NCFS000	C0030664	calificador	332-341	310_QUEST_clinical_caseMIR	SENT2	-	-
15	de	de	SPS00	C0332285	atributo	342-344	310_QUEST_clinical_caseMIR	SENT2	-	-
16	base	base	NCCS000	C1626935#C0178499	calificador#sustancia	345-349	310_QUEST_clinical_caseMIR	SENT2	-	-
17	,	,	Fc	-	-	349-350	310_QUEST_clinical_caseMIR	SENT2	-	-
18	posibles	posible	AQ0CP0	C0332149#C2362652	calificador	351-359	310_QUEST_clinical_caseMIR	SENT2	-	-
19	eventos	evento	NCMP000	C0441471	evento	360-367	310_QUEST_clinical_caseMIR	SENT2	-	-
20	adversos	adverso	AQ0MP0	-	-	368-376	310_QUEST_clinical_caseMIR	SENT2	-	-
21	del	del	SP+DA	-	-	377-380	310_QUEST_clinical_caseMIR	SENT2	-	-
22	tratamiento	tratamiento	NCMS000	C0279025_1	procedimiento_1	381-392	310_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
23	hormonal	hormonal	NC00SC0	C0279025_2	procedimiento_2	393-401	310_QUEST_clinical_caseMIR	SENT2	I-Grp_Medicamento	-
24	y	y	CC	C1706368	calificador	402-403	310_QUEST_clinical_caseMIR	SENT2	-	-
25	probabilidades	probabilidad	NCFP000	-	-	404-418	310_QUEST_clinical_caseMIR	SENT2	-	-
26	de	de	SPS00	C0332285	atributo	419-421	310_QUEST_clinical_caseMIR	SENT2	-	-
27	tener	tener	VMN0000	-	-	422-427	310_QUEST_clinical_caseMIR	SENT2	-	-
28	descendencia	descendencia	NCFS000	-	-	428-440	310_QUEST_clinical_caseMIR	SENT2	-	-
29	en	en	SPS00	C1720294#C0332285	calificador#atributo	441-443	310_QUEST_clinical_caseMIR	SENT2	-	-
30	un	un		C0205447_1	calificador_1	444-446	310_QUEST_clinical_caseMIR	SENT2	-	-
31	futuro	futuro	NCMS000	-	-	447-453	310_QUEST_clinical_caseMIR	SENT2	-	-
32	.	.	Fp	-	-	453-454	310_QUEST_clinical_caseMIR	SENT2	-	-

1	Cuál	cuál	PT0CS000	-	-	455-459	310_QUEST_clinical_caseMIR	SENT3	-	-
2	de	de	SPS00	C0332285	atributo	460-462	310_QUEST_clinical_caseMIR	SENT3	-	-
3	las	el	DA0FP0	-	-	463-466	310_QUEST_clinical_caseMIR	SENT3	-	-
4	siguientes	siguiente	AQ0CP0	C0332282	atributo	467-477	310_QUEST_clinical_caseMIR	SENT3	-	-
5	aseveraciones	aseveración	NCFP000	C1301625	calificador	478-491	310_QUEST_clinical_caseMIR	SENT3	-	-
6	NO	no	RN	C1298908	calificador	492-494	310_QUEST_clinical_caseMIR	SENT3	-	-
7	es	ser	VSIP3S0	-	-	495-497	310_QUEST_clinical_caseMIR	SENT3	-	-
8	correcta	correcto	AQ0FS0	C0205170	calificador	498-506	310_QUEST_clinical_caseMIR	SENT3	-	-
9	.	.	Fp	-	-	506-507	310_QUEST_clinical_caseMIR	SENT3	-	-

